Cleared Traditional

Reselute Tibial Nail

K253517 · Reselute, Inc. · Orthopedic
Mar 2026
Decision
118d
Days
Class 2
Risk

About This 510(k) Submission

K253517 is an FDA 510(k) clearance for the Reselute Tibial Nail, a Rod, Fixation, Intramedullary And Accessories (Class II — Special Controls, product code HSB), submitted by Reselute, Inc. (Durham, US). The FDA issued a Cleared decision on March 10, 2026, 118 days after receiving the submission on November 12, 2025. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3020.

Submission Details

510(k) Number K253517 FDA.gov
FDA Decision Cleared SESE
Date Received November 12, 2025
Decision Date March 10, 2026
Days to Decision 118 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code HSB — Rod, Fixation, Intramedullary And Accessories
Device Class Class II — Special Controls
CFR Regulation 21 CFR 888.3020

Similar Devices — HSB Rod, Fixation, Intramedullary And Accessories

All 519
Affixus Retrograde Femoral Nailing System
K253566 · Zimmer, Inc. · Mar 2026
Arthrex FibuLock Nail System
K252196 · Arthrex, Inc. · Mar 2026
Phantom? Hindfoot TTC/TC Nail System
K253591 · Paragon 28, Inc. · Mar 2026
Active Intramedullary (AIM) Tibial Nail System
K252025 · Satori Orthopaedics, Inc. · Mar 2026
T2 Alpha Femur Retrograde Nailing System; Pangea Femur Reconstruction System
K253640 · Stryker GmbH · Feb 2026
Affixus? Natural Nail? Proximal Humeral System
K253749 · Zimmer Switzerland Manufacturing GmbH · Dec 2025